Latest News about RXRX
Recent news which mentions RXRX
   Cathie Wood's Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note
   
  
  
  January 04, 2025
  From Benzinga
 
   Nio, Unity Software And Other Big Stocks Moving Higher On Thursday
   
  
  
  January 02, 2025
  From Benzinga
 
   Is Recursion Pharmaceuticals Stock a Millionaire Maker?
   
  December 21, 2024
  Tickers 
   RXRX
  
  
  From Motley Fool
 
   1 Artificial Intelligence (AI) Stock That Could Soar in 2025
   
  
  
  December 21, 2024
  From Motley Fool
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  December 11, 2024
  From Benzinga
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  December 10, 2024
  From Benzinga
 
   What's Going On With Recursion Pharmaceuticals Stock?
   
  
  
  December 10, 2024
  From Benzinga
 
   An Investor's Guide to the Artificial Intelligence (AI) Value Chain
   
  
  
  December 09, 2024
  From Motley Fool
 
   Ulta Beauty Posts Upbeat Results, Joins Asana, Lululemon, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Friday
   
  
  
  December 06, 2024
  From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  December 04, 2024
  From Benzinga
 
   Berkshire Hathaway Isn't the Only Publicly Traded Company That Buys Stocks. These 3 Tech Giants Also Have Stock Portfolios.
   
  
  
  December 04, 2024
  From Motley Fool
 
   XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
   
  
  
  December 02, 2024
  From Benzinga
 
   (RXRX) - Analyzing Recursion Pharmaceuticals's Short Interest
   
  November 28, 2024
  Tickers 
   RXRX
  
  
  From Benzinga
 
   Jim Cramer: Reddit Is 'Fabulous,' Dow Is A 'Tough' One
   
  
  
  November 27, 2024
  From Benzinga
 From Benzinga
 
   2 Innovative Stocks That Could Deliver Outsize Returns
   
  
  
  November 22, 2024
  From Motley Fool
 
   Nvidia Reveals 3.6% Stake In Applied Digital, Stock Soars
   
  
  
  November 15, 2024
  From Benzinga
 
   MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
   
  
  
  November 11, 2024
  From Benzinga
 
   A Closer Look at 4 Analyst Recommendations For Recursion Pharmaceuticals
   
  November 07, 2024
  Tickers 
   RXRX
  
  
  From Benzinga
 
   Peering Into Recursion Pharmaceuticals's Recent Short Interest
   
  November 04, 2024
  Tickers 
   RXRX
  
  
  From Benzinga
 
   10 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  November 04, 2024
  From Benzinga
 
   Is Recursion Pharmaceuticals a Millionaire-Maker Stock?
   
  November 02, 2024
  Tickers 
   RXRX
  
  
  From Motley Fool
 
   Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
   
  
  
  October 31, 2024
  From Benzinga
 
   3 Key Trends That Are Bullish for Recursion Pharmaceuticals Stock
   
  October 26, 2024
  Tickers 
   RXRX
  
  
  From Motley Fool
 
   Prediction: These 2 Stocks Could Soar in 2025
   
  
  
  October 17, 2024
  From Motley Fool
 
   Cathie Wood Is Betting on This AI Stock: Is It a Buy?
   
  October 15, 2024
  Tickers 
   RXRX
  
  
  From Motley Fool
 
   Down 57% in 2024, Is Recursion Pharmaceuticals a Buy on the Dip?
   
  October 15, 2024
  Tickers 
   RXRX
  
  
  From Motley Fool
 
   Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
   
  
  
  October 08, 2024
  From Motley Fool
 
   2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
   
  
  
  October 07, 2024
  From Motley Fool
 
   2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
   
  
  
  September 29, 2024
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
